ALB and COVID-19: A recent report of dialysis patients with COVID-19 in Japan revealed that older age (> 70 years), higher BMI, higher CRP level, and lower serum albumin levels, were aggravating factors of mortality, and that the use of remdesivir was predictive of improved mortality [22].